Atlas Trials

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Clinical trial NCT06193993 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06193993
Sponsor
National University Hospital, Singapore
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate CancerMetastatic CancerHormone Sensitive Prostate CancerCastration-resistant Prostate Cancer
Start date
2021-11-30
Primary completion
2023-09-05
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.